CRDL
CRDL
NASDAQ · Pharmaceuticals

Cardiol Therapeutics Inc-A

$1.05
+0.06 (+5.54%)
As of Mar 24, 10:09 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +2,212.4% upside
Low Target $16.80
Average Target $24.28
High Target $33.59
Current Price $1.05
Current
$1.05
Target
$24.28
$16.80 $24.28 avg $33.59
Scenario Analysis
Bear Case
$16.80
1,500.0%
Low target
Base Case
$24.28
+2,212.4%
Avg target
Bull Case
$33.59
+3,099.0%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$2.17
-51.6% from high
52-Week Low
$1.09
+-3.7% from low
Target vs 52W High
$24.28
+1,018.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%